Abstract
Background: The inhibition of key enzymes involved in type II diabetes and Alzheimer’s disease is an effective therapeutic approach for managing these health disorders. This study aimed to assess the antidiabetic and neuroprotective effects of Pistacia lentiscus L.
 Methods: The potential of Pistacia lentiscus L. fatty oil (PLFO) was investigated against the activities of α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase. Additionally, the unsaponifiable matter (USM) of this oil was isolated and screened for the same activities. Furthermore, the antioxidant power of both extracts was evaluated using DPPH, ABTS, and CUPRAC assays.
 Results: The results revealed that PLFO exhibited a low antioxidant effect primarily due to its USM. The potent antidiabetic effect of PLFO was also attributed to its USM, while the whole oil was responsible for the neuroprotective effect.
 Conclusion: These findings suggest that PLFO and its USM could serve as natural sources of compounds for managing type II diabetes and Alzheimer’s disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
